On March 5, 2018 CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in upcoming investor conferences, including the 30th Annual ROTH Conference, the H.C. Wainwright 2nd Annual NASH Investor Event, and the Oppenheimer & Company 28th Annual Healthcare Conference (Press release, CymaBay Therapeutics, MAR 5, 2018, View Source [SID1234524388]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

30th Annual ROTH Conference 2018
Date: Monday, March 12
Time: 9am Pacific Time
Location: Ritz Carlton, Laguna Niguel, CA

H.C. Wainwright 2nd Annual NASH Investor Event
Date: Monday, March 19
Time: 9:20am Eastern Time
Location: St. Regis Hotel, New York, NY
Webcast: View Source

Oppenheimer & Company 28th Annual Healthcare Conference
Date: Tuesday, March 20
Time: 9:10am Eastern Time
Location: Westin New York Grand Hotel, NY
Webcast: View Source